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A quantitative analysis of relationships between structures of a series of carboxamide 
derivatives of 5’-amino-2’,5’-dideoxy-5-ethyluridine and N2-phenylguanines and efficiency of 
inhibition of the catalytic activity of murine herpes simplex virus thymidine kinase (HSV-TK types I 
and II) was made by the program GUSAR 2013 (General Unrestricted Structure Activity 
Relationships) [1-2]. Biological data from ChEMBL [3] were used for creation of QSAR models. In 
general 40 statistically significant QSAR-models (Rtrain set
2
> 0.6, Rtest set
2
> 0.5, Q
2
> 0.6) for 
prediction of IC50 values for various 5’-amino-2’,5’-dideoxy-5-ethyluridine and N
2
-phenylguanines 
against murine HSV-TK (types I and II) were created based on MNA- and QNA-descriptors, as well 
as consensus of their combinations. The statistical characteristics of some of the models we 
constructed are presented in the Table1. Training set TrS2 and test set TS included 59 and 15 
structures of murine HSV-TK (types I) inhibitors, respectively. They were obtained by dividing the 
pre-sorted in ascending order of IC50 values in ratio 3:1, i.e. excluded from TrS1 every fourth 
compound to murine HSV-TK (types I). Similarly, we simulated the antiviral activity of the same 
compounds for murine HSV-TK type 2. All QSAR-models can be used for quantitative prediction of 
potential antiviral drugs against murine HSV-TK (types I and II). Atoms and structural fragments of 
the studied structures influencing on increase and decrease of HSV-TK (types I and II)  inhibition 
were identified. These results can be considered in the molecular design of active substances of 
known antiviral drugs in order to enhance their antiviral activity.  
Table 1. Characteristics and prediction accuracy of IC50 values for consensus models M1 - 
M6. pIC50 activity in TrS1 and TrS2 lies in the range -5.146 ‒ 0.721. 
Training set Models N R
2
ОВ R
2
ТВ F S.D. Q
2
 V 
QSAR model based on QNA-descriptors 
TSet1 М1 59 0.910  88.007 0.561 0.889 6 
TSet2 М2 44 0.941 0.835 100.927 0.453 0.925 8 
QSAR model based on MNA-descriptors 
TSet1 М3 59 0.920 - 94.881 0.527 0.905 6 
TSet2 М4 44 0.940 0.832 96.837 0.457 0.923 6 
QSAR model based on MNA- and QNA-descriptors 
TSet1 М5 59 0.925 - 87.303 0.513 0.907 7 
TSet2 М6 44 0.936 0.847 80.444 0.473 0.916 8 
N – number of structures in the training set; R2TrS - a multiple coefficient of determination calculated 
for compounds from the training set; R
2
TS - a multiple coefficient of determination calculated for 
compounds from the test set; Q
2
 – a cross-validated R2 calculated during leave-one-out cross-
validation procedure on data of the training set; F – Fisher's coefficient; S.D. – standard deviation; 
V- the number of variables in the final regression equation. 
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